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Abstract
As in many other types of cells, retinal pigment epithelial (RPE) cells have an active ubiquitineproteasome pathway (UPP). However, the func-
tion of the UPP in RPE remains to be elucidated. The objective of this study is to determine the role of the UPP in controlling the levels and
activities of transcription factors hypoxia-inducible factor (HIF) and NF-kB. We inhibited the UPP with proteasome-specific inhibitors and de-
termined the activation of HIF and NF-kB as well as the expression and secretion of pro-angiogenic factors. HIF-1a was not detectable in ARPE-
19 cells under normal culture conditions. However, when proteasome activity was inhibited, HIF-1a accumulated in RPE in a time-dependent
manner. Consistent with accumulation of HIF-1a in the cells, levels of mRNA for vascular endothelial growth factor (VEGF) and angiopoietin-2
(Ang-2) in RPE were up to 7-fold higher upon inhibition of the proteasome. Proteasome inhibition was also associated with a 2-fold increase in
levels of mRNA for angiopoietin-1 (Ang-1). ARPE-19 cells secrete significant levels of VEGF under normal culture conditions. Inhibition of
proteasome activity increased the secretion of VEGF by 2-fold. In contrast to the increase in HIF activity, NF-kB activation was reduced by
proteasome inhibition. In addition, the expression and secretion of monocyte chemoattractant protein-1 (MCP-1) by RPE were substantially at-
tenuated by the inhibition of proteasome activity. These data demonstrate that the UPP plays an important role in modulating the activities of
HIF and NF-kB in the RPE. Consequences of an impairment of the UPP include accumulation of HIF-1a and diminished NF-kB activation,
which lead to enhanced expression and secretion of pro-angiogenic factors and attenuated expression of MCP-1. Taken together, these data pre-
dict that the impairment of the UPP could lead to the development of AMD-related phenotypes.
 2006 Elsevier Ltd. All rights reserved.
Keywords: age-related macular degeneration; angiogenesis; signal transduction; retinal pigment epithelium; ubiquitin; proteasome; hypoxia-inducible factor;
vascular endothelial growth factor; monocyte chemoattractant protein-11. Introduction
The ubiquitin-proteasome pathway (UPP) is the major
non-lysosomal proteolytic pathway within cells (Glickman
and Ciechanover, 2002; Ciechanover, 2003). In this pathway,
proteins destined for degradation must be conjugated with
a ubiquitin chain in order to be recognized and degraded by
* Corresponding author. Tel.: þ1 617 556 3158; fax: þ1 617 556 3132.
E-mail address: fu.shang@tufts.edu (F. Shang).0014-4835/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.exer.2006.07.024a large protease complex called the proteasome. Ubiquitin con-
jugation, or ubiquitination, is a highly ordered process in which
a ubiquitin-activating enzyme (E1) first activates and transfers
ubiquitin to a ubiquitin-conjugating enzyme (E2), which then
acts in concert with one of a large family of ubiquitin protein
ligases (E3) to transfer ubiquitin to a lysine residue on the tar-
get substrate (Pickart, 2001; Glickman and Ciechanover,
2002). In most cases, additional ubiquitins are conjugated to
the initial ubiquitin moiety to form polyubiquitin chains. A
chain of at least four ubiquitin moieties is required for substrate
recognition by the 26S proteasome complex (Beal et al., 1996;
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sists of a 20S proteolytic core and typically two regulatory 19S
caps. The 19S cap cleaves ubiquitin moieties from the sub-
strate, unfolds the polypeptide and feeds it through the narrow
channel of the proteolytic chamber of the 20S core (DeMartino
and Slaughter, 1999).
The UPP is an important protein quality control system
(Goldberg, 2003), which selectively degrades mutant, mis-
folded, or damaged proteins (Ward et al., 1995; Shang et al.,
2001; Marques et al., 2004). Timely removal of abnormal or
damaged proteins by the UPP is essential for the cells to with-
stand and recover from various environmental stresses (Dudek
et al., 2005; Shang et al., 2005). However, the UPP itself is
also a target of such stresses. All of the three classes of ubiq-
uitination enzymes (E1, E2 and E3) have a cysteine in their ac-
tive sites and therefore the activities of these enzymes are
subject to redox regulation (Jahngen-Hodge et al., 1997;
Obin et al., 1998). S-Nitrosylation could also inactivate these
enzymes (Yao et al., 2004). Reactive oxygen species and reac-
tive lipid peroxidation products, such as 4-hydroxynonenal,
also impair the function of the proteasome (Conconi et al.,
1998; Okada et al., 1999; Caballero et al., 2003; Ishii et al.,
2005). Since the UPP plays critical roles in almost every as-
pect of cellular function, abnormal regulation or inactivation
of this pathway has been implicated in many age-related
diseases, such as Alzheimer’s disease (Hope et al., 2003),
Parkinson’s disease (Dawson and Dawson, 2003), and cataract
(Jahngen-Hodge et al., 1992; Shang et al., 1997; Shang et al.,
2001; Dudek et al., 2005).
Like most other types of cells, RPE have an active UPP. In
a cell-free system, RPE supernatant is capable of degrading
a variety of substrates for the UPP, such as histone 2A, oxi-
dized RNase, transducin, and b-lactoglobulin (Obin et al.,
1994, 1995). In contrast with many other types of cells, RPE
have limited levels of free ubiquitin. Thus, addition of exoge-
nous ubiquitin to RPE supernatant generated significantly
higher levels of ubiquitin conjugates and also enhanced the
proteasome-dependent proteolysis (Obin et al., 1994, 1995;
Shang et al., 2005). The limited levels of endogenous ubiquitin
may render the UPP in RPE more vulnerable to a variety of
environmental stresses.
Age-related macular degeneration (AMD) is a complex and
multifactorial disease and the leading cause of blindness in in-
dustrialized countries. The mechanism of this disease remains
elusive and current therapeutic options are limited. An increas-
ing body of literature indicates that development of AMD is
related to dysfunction of RPE (Boulton et al., 2004; Zarbin,
2004; Zhou et al., 2005). One essential function of the postmi-
totic RPE is phagocytosis and degradation of shed photorecep-
tor outer segments. The completely degraded material is
subsequently released at the basal side, where it is normally
cleared by the choriocapillaris. Another function of RPE is
to nurture photoreceptors and choriocapillaris by secreting
various growth factors and cytokines, such as pigment epithe-
lium-derived factor (PEDF), vascular endothelial growth
factor (VEGF) and monocyte chemoattractant protein-1
(MCP-1) (Elner et al., 1997; Schlingemann, 2004).Choroidal neovascularization (CNV) represents the most
common cause of severe vision loss in AMD (Ambati
et al., 2003a; Ishida et al., 2003). Maintenance of the physi-
ological architecture of the choriocapillaris requires a well-
regulated balance between various factors derived from the
RPE, such as PEDF, VEGF, angiopoietin-1 (Ang-1) and
angiopoietin-2 (Ang-2). VEGF, which can be induced by
hypoxia, induces the formation of new blood vessels (Ishida
et al., 2003), while PEDF serves as an inhibitory factor. In
addition to VEGF and PEDF, recent results indicate that
Ang-1 and Ang-2 and their receptor Tie-2 play a role in
the formation of CNV (Hangai et al., 2001; Jain, 2003).
Ang-1 promotes vascular integrity and maturation, inhibits
apoptosis, and reduces vascular permeability. Ang-2 is an an-
tagonist of Ang-1 and promotes VEGF-induced proliferation
of endothelial cells. The receptor Tie-2, along with Ang-1
and Ang-2, was shown to be present in choroidal neovascular
tissue (Hangai et al., 2001). The expression and secretion of
VEGF, PEDF, Ang-1 and Ang-2 are under the control of the
hypoxia-inducible factor (HIF), either directly or indirectly
(Pugh and Ratcliffe, 2003). HIF is an ab-heterodimer, first
recognized as a DNA-binding factor that mediates hypoxia-
induced activity of the erythropoietin 30 enhancer (Semenza
and Wang, 1992; Wang et al., 1995). In addition, the HIF sys-
tem is a key regulator of a broad range of hypoxia-related
processes, including angiogenesis (Wenger, 2002). Both
HIF-1a and HIF-1b subunits exist as a series of isoforms
encoded by distinct genetic loci. HIF-1b subunits are con-
stitutive nuclear proteins, whereas HIF-1a subunits are induc-
ed by hypoxia. The abundance of HIF-1a subunits is mainly
regulated by the rate of degradation. Oxygen-dependent
hydroxylation at two proline residues (Pro402 and Pro564)
of human HIF-1a mediates its interactions with a ubiquitin
ligase (E3), von HippeleLindau (VHL), which targets HIF-
1a for proteasomal degradation (Ivan et al., 2001; Jaakkola
et al., 2001), and contributes to the extremely rapid proteol-
ysis of HIF-1a in cells under normoxia conditions (Masson
et al., 2001).
In addition to HIF, other transcription factors, such as NF-
kB, are also under the control of the UPP. NF-kB proteins are
present in the cytoplasm in association with inhibitory proteins
called inhibitors of kB (I-kBs). Upon activation by a variety of
inducers, the I-kB proteins are phosphorylated, ubiquitinated,
and subsequently degraded by the proteasome (Maniatis,
1999; Tanaka et al., 2001). Degradation of I-kB allows the
translocation of NF-kB into the nucleus and binding to its cog-
nate DNA binding sites to regulate the transcription of a large
number of genes, including those involved in angiogenesis,
such as cytokines and stress response proteins.
Given the fact that several transcription factors, such as HIF-
1a and NF-kB, are under the control of the UPP (Alkalay et al.,
1995; Cho et al., 2001), we hypothesized that impairment of
the UPP in RPE could result in altered gene expression that
promotes the development of AMD-like phenotypes. To test
this hypothesis, we inhibited proteasome activity in cultured
RPE and assessed the effects on the expression and secretion
of growth factors and chemokines that may be involved in
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the UPP in RPE results in the accumulation of HIF-1a and
an increase in the expression of VEGF and Ang-2. In addition,
inhibition of the UPP in RPE also decreases the expression of
MCP-1. Because overproduction of VEGF and deficiency in
MCP-1 are both associated with development of AMD (Ambati
et al., 2003b), these data support our hypothesis that impair-
ment of the UPP in RPE could contribute to the development
of AMD.
2. Materials and methods
2.1. Cell culture and treatments
The retinal pigment epithelial cell line ARPE-19 (Dunn
et al., 1996) was obtained from ATCC. The cells were rou-
tinely maintained at 37 C under 5% CO2 atmosphere and cul-
tured in Dulbecco’s modified Eagle medium (DMEM; Gibco/
BRL, Gaithersburg, MD, USA) supplemented with 10% fetal
bovine serum (HyClone, Logan, UT, USA) and containing
100 U/ml penicillin G and 100 mg/ml streptomycin. Most of
the experiments were performed using subconfluent (w90%
confluence) RPE (Figs. 1e5). To determine if these findings
pertain to differentiated RPE, the cells were cultured under
confluent conditions for 3 weeks and then treated with protea-
some inhibitors (Fig. 6). Before treatments, cell monolayers
were rinsed once with PBS and fresh medium was added.
For proteasome inhibition studies, MG132 (Calbiochem, La
Jolla, CA, USA) and epoxomicin (Boston Biochem, Cam-
bridge, MA, USA) were prepared in DMSO at 10 mM and
diluted to10 mM (MG 132) and 5 mM (epoxomicin) in the cul-
ture medium immediately before use. Cells were incubated
with proteasome inhibitors for different periods of time as
indicated in the figure legends. For hypoxia studies, ARPE-
19 cells were cultured in 21% or 1% oxygen for 16 h, or first
in 1% for 16 h and then returned to 21% for 5 min. The hyp-
oxic cell culture was performed in an INVIVO2 200 hypoxia
working station (Biotrace, Bridgend, UK). To test the effect
of HIF-1a levels on VEGF expression, sub-confluent RPE
were transfected with empty pcDNA3 vector or pcDNA3-
HIF-1a using Superfect transfect reagent (Qiagen, Valencia,
CA, USA). Cellular RNAwas extracted 48 h after transfection
for determining VEGF mRNA levels.2.2. Western blot analysis
Whole cell lysates were prepared for the use in Western
blot analysis. After treatment, cells were rinsed once with
ice-cold PBS and immediately collected in SDS loading
buffer. Since SDS-gel loading buffer is not compatible with
most of the commonly used protein quantification methods,
we assessed the protein concentrations in the lysate by deter-
mining the densities of the protein bands on the gel after sep-
aration on SDSePAGE and staining with Coomassie brilliant
Blue R-250. Standard curves were established using 3 known
concentrations of RPE supernatant. Cell lysates were then
denatured at 100 C for 3 min. Equal amounts of protein
(20 mg) were resolved on 7.5e12% SDSepolyacrylamide
gels and transferred to nitrocellulose membranes (Bio-Rad
Laboratories, Hercules, CA, USA). Membranes were probed
with rabbit polyclonal antibody against ubiquitin (produced
in New Zealand White rabbits in this laboratory, 1:1000
dilution), or mouse monoclonal antibodies against HIF-1a
(Novus Biologicals, Littleton, CO, USA) (1:500 dilution)
and b-actin (Sigma, St. Louis, MO, USA) (1:10,000 dilu-
tion). After incubation with corresponding HRP-conjugated
secondary antibodies (Jackson ImmunoResearch Laborato-
ries, West Grove, PA, USA), the specific bound antibody
was visualized using Super Signal chemiluminescence detec-
tion kit (Pierce, Rockford, IL, USA).
2.3. Enzyme-linked immunosorbent assay (ELISA)
Levels of VEGF and MCP-1 secreted into the medium by
RPE were determined by ELISA. The DuoSet ELISA kits
were obtained from R&D Systems (Minneapolis, MN,
USA). The medium was diluted 2 times for determining
VEGF levels and 10 times for determining levels of MCP-1.
All ELISAs were performed according to the manufacturer’s
instructions.
2.4. Real-time RTePCR
Total RNA was extracted from ARPE-19 cells using the
RNeasy mini kit (Qiagen). Two micrograms of total RNA
from each sample were used for reverse transcription using Su-
perScript First-Strand Synthesis System for RTePCRFig. 1. Hypoxia or inhibition of proteasome stabilizes HIF-1a in cultured RPE. (A) ARPE-19 cells were cultured in 21% oxygen (lane 1) or 1% oxygen for 16 h
(lane 2), or first in 1% oxygen for 16 h and then returned to 21% oxygen for 5 min (lane 3). (B, C) ARPE-19 cells were cultured under normoxic conditions (21%
oxygen) with or without proteasome inhibitors (MG132 or epoxomicin) for 8 h. Levels of endogenous ubiquitin conjugates (B) and HIF-1a (A, C) were determined
by Western blotting analysis using a polyclonal anti-ubiquitin antibody or a monoclonal anti-HIF-1a antibody. (A) and (C) represent the data of five independent
experiments with similar results whereas (B) was repeated twice with similar results.
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or without MG132 for 8 h, or cultured under hypoxic conditions (1% oxygen) for 16 h. (C) ARPE-19 were transfected with empty pcDNA3 vector or pcDNA3-
HIF-1a for 48 h. VEGF mRNA levels were determined by real-time RTePCR assay (A and C). GAPDH mRNAwas used as a control to normalize the total mRNA
levels. VEGF protein levels in the medium were determined by ELISA (B). Results are given as mean  S.D. of three different experiments. *P < 0.05, and
**P < 0.01.(Invitrogen, Carlsbad, CA, USA). The sequences of the
primers used for real-time RTePCR are summarized in Table
1. Real-time RTePCR analysis was conducted on Stratagene
Mx4000 multiplex quantitative PCR system using SYBR
Green PCR master mix (Qiagen) according to the manufactur-
er’s instructions. The expression levels of the genes of interest
were normalized using GAPDH as a housekeeping gene.
2.5. Preparation of nuclear extracts and
DNA-binding assays
Following treatment of cell cultures, cells were rinsed with
ice-cold PBS containing 1 mM EDTA and collected by scrap-
ing. After a brief centrifugation, the cell pellet was resus-
pended in ice-cold hypotonic lysis buffer (10 mM HEPES,
pH 7.9, 0.1 mM EDTA, 0.1 mM EGTA, 10 mM KCl, 0.3%
NP-40, 1 mM DTT, 1 mM AEBSF). After 15 min incubation
on ice, the lysates were vortexed and centrifuged at
15,000  g for 15 s to recover intact nuclei. The nuclear pel-
lets were rinsed in the above buffer without NP-40 and then
resuspended in ice-cold nuclear protein extraction buffer
(20 mM HEPES, pH 7.9, 420 mM NaCl, 1 mM EDTA,
0.1 mM EGTA and a cocktail of protease inhibitors) and incu-
bated on ice for an additional 30 min. The samples were
centrifuged at 15,000  g for 5 min. The resulting superna-
tants, the source of DNA-binding proteins, were mixed 1:1
with ice-cold 20 mM HEPES, pH 7.9, 20% glycerol,
100 mM KCl, 1 mM EDTA, 0.1 mM EGTA, 1% NP-40 and
stored at 70 C until use. Protein concentrations in theextracts were determined by the Coomassie Plus protein assay
(Pierce), using bovine serum albumin as the standard.
Electrophoretic mobility shift assays were used to deter-
mine the DNA binding activity of NF-kB in the nuclear
extracts. Briefly, equal amounts of nuclear extract (2 mg pro-
tein) were incubated for 20 min at RT with 10 fmol of 32P-la-
beled oligonucleotide (1  105 cpm) specific for NF-kB in
20 ml binding buffer (10 mM TriseHCl, pH 7.5, 50 mM
NaCl, 1 mM MgCl2, 1 mM DTT, 1 mM EDTA, 4% glycerol,
1 mg poly(dI-dC), 1 mg BSA). The DNAeprotein complexes
formed were resolved on 5% nondenaturing polyacrylamide
gels using 0.5 TBE (45 mM Triseborate and 1 mM
EDTA). Autoradiography was performed to visualize the
shifted DNAeprotein complexes. The NF-kB DNA-binding
double-stranded oligonucleotide used was 50-AGTTGAGGG-
GACTTTCCCAGGC-30 (Promega, Madison, WI, USA). Spe-
cific DNA-binding complexes of NF-kB were identified as the
band that disappeared when 50-fold excess of cold oligonucle-
otide competitor was added in binding assays. For supershift
analysis, specific antibodies against NF-kB subunits were
added for 30 min before binding reactions started and super-
shifts were resolved as indicated above. Antibodies used
were RelA(p65) (sc-109) and NFkB1(p50) (sc-114) (Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA).
2.6. Statistical analyses
Statistical analysis was performed using Student’s t-test as-
suming equal variances for all data points.Fig. 3. Time course of proteasome inhibition-induced expression of pro- angiogenic factors in RPE. ARPE-19 cells were cultured in the presence of MG132 for 0,
2, 4, and 8 h. Total RNA was extracted from these cells and levels of VEGF (A), Ang-1 (B) and Ang-2 (C) were determined by real-time RTePCR analysis.
GAPDH mRNAwas used as a control to normalize the total mRNA levels. Results are given as mean  S.D. of three different experiments. *P < 0.05, **P < 0.01.
1476 A.F. Fernandes et al. / Experimental Eye Research 83 (2006) 1472e1481Fig. 4. Proteasome inhibition decreases NF-kB activation. ARPE-19 cells were cultured in the presence or absence of MG132 for 30 and 60 min, nuclear extracts
were prepared, and electrophoretic mobility shift assays were performed for NF-kB binding (A). The specific DNA-binding complexes of NF-kB were identified as
the band that disappeared in the presence of 50-fold excess of cold oligonucleotide competitor in the binding assay (A, lane 5). The effects of TNFa and protea-
some inhibition on NF-kB activity are shown in (B). Supershift analysis using specific antibodies to RelA(p65) and NF-kB1(p50) (C). Arrows indicate NF-kB-
specific DNA-binding complexes and the corresponding supershifted DNA complexes identifying RelA(p65) and NFkB1(p50) as protein subunits of NF-kB. The
figure represents the data of three independent experiments with similar results.3. Results
3.1. Levels of HIF-1a in RPE are regulated in an
oxygen-and proteasome dependent manner
HIF-1 is an ab-heterodimer composed of HIF-1a and HIF-
1b. HIF-1b subunit is a constitutive nuclear protein and there-
fore the HIF-1 activity is controlled by levels of HIF-1a. It has
been demonstrated in other types of cells that the abundance of
HIF-1a subunit is mainly regulated by oxygen-dependent hy-
droxylation and subsequent UPP-mediated degradation. How-
ever, the molecular regulation of HIF activity in RPE is poorly
understood. To determine if HIF-1a levels in RPE cells are
regulated in an oxygen dependent manner, confluent mono-
layers of ARPE-19 were cultured under normoxic (21% oxy-
gen) or hypoxic conditions (1% oxygen) for 16 h and the
levels of HIF-1a were determined by Western blotting. As in
many other types of cells, HIF-1a was barely detectable in
ARPE-19 cells when they were cultured under normoxic con-
ditions (Fig. 1A and C, lane 1). In contrast, when RPE were
cultured under hypoxic conditions (1% oxygen), HIF-1a was
readily detected (Fig. 1A, lane 2). When hypoxia-treated
ARPE-19 cells were returned to normoxic conditions, levels
of HIF-1a decreased rapidly (Fig. 1A, lane 3). The half-life
of HIF-1a was w5 min under normoxic conditions.
To further determine if levels of HIF-1a in RPE were reg-
ulated by UPP-mediated degradation, we assessed the effects
of proteasome inhibition on HIF-1a levels in ARPE-19 cellscultured under normoxic conditions (21% oxygen). Upon
treatment with 10 mM MG132 or 5 mM epoxomicin, two
commonly used inhibitors of the proteasome, the levels of
endogenous ubiquitin-protein conjugates increased w2-fold
(Fig. 1B, compare lanes 2 and 3 with lane 1), indicating that
proteasome activity is inhibited. Peptidase activity assays
showed that the chymotrypsin-like activity of the proteasome
was inhibited by 90% under these conditions. HIF-1a levels
in RPE increased in a time-dependent manner upon inhibition
of the proteasome by MG132 or epoxomicin and reached the
maximum by 8 h. Fig. 1C shows HIF-1a levels in RPE upon
8 h of proteasome inhibition (compare lanes 2 and 3 with
lane 1). High molecular weight species that react with anti-
HIF-1a antibody were also detected upon inhibition of protea-
some (similar to those shown in Fig. 6A). The high molecular
weight species that react with HIF-1a are probably the ubiqui-
tin-HIF-1a conjugates, but their identities remain to be further
verified. The data show that levels of HIF-1a in RPE are con-
trolled by UPP- mediated degradation and that impairment of
the UPP in RPE can result in the accumulation of HIF-1a,
even under normoxic conditions.
3.2. Proteasome inhibition in RPE results in enhanced
expression and secretion of VEGF and
other pro-angiogenic factors
To assess the physiological consequences of proteasome in-
hibition and elevated levels of HIF-1a in RPE, we examinedFig. 5. Proteasome inhibition down-regulates MCP-1 in RPE. ARPE-19 cells were cultured in the presence of MG132 for 0, 4, and 8 h. Levels of mRNA for MCP-1
were assessed by real-time RTePCR analysis (A). GAPDH mRNAwas used as a control to normalize the total mRNA levels. Levels of MCP-1 in the medium were
detected by ELISA after the ARPE-19 cells were cultured in the presence or absence of MG 132 for 4 and 8 h (B) or after stimulation with or without TNFa in the
absence or presence of MG132 for 8 h (C). The data presented is the result of three different experiments. *P < 0.01 in comparison with cells not treated with
proteasome inhibitor in the absence of TNFa. #P < 0.01 in comparison between TNFa-treated and untreated cells in the absence of proteasome inhibitor.
##P < 0.01 in comparison between MG132-treated and untreated cells in the presence of TNFa.
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tured under confluent conditions for 3 weeks and then treated with 10 mMMG132 or 5 mM epoxomicin for 8 h in fresh medium. Levels of HIF-1a were detected by
Western blot (A). Levels of VEGF (B) and MCP-1 (C) in the medium were determined by ELISA. (A) represents the results of two independent experiments. (B)
and (C) are given as mean  S.D. of three different experiments.the expression and secretion of VEGF, Ang-1 and Ang-2. The
UPP plays important roles in many aspects of cellular func-
tions. To avoid cytotoxicity associated with prolonged UPP in-
hibition, we determined the time course of VEGF expression
and secretion upon proteasome inhibition (0, 2, 4, 8, 16 and
24 h). We found that the expression of VEGF started to in-
crease after inhibiting the proteasome for 4 h and this increase
lasted w16 h. If the proteasome was inhibited for longer than
16 h, the expression of VEGF, along with many other genes
we have tested, decreased. The cross board decline in gene ex-
pression associated with prolonged proteasome inhibition
might be caused by cytotoxicity of the inhibitors. Therefore,
we only presented the data obtained upon 8 h of proteasome
inhibition. As shown in Fig. 2A, mRNA levels for VEGF in-
creased 3- or 6-fold upon hypoxia treatment or inhibition of
the proteasome, respectively. Consistent with previous work
(Zhou et al., 2005), we found that RPE cells secrete significant
amounts of VEGF even under normal conditions. The concen-
tration of VEGF-A165 in RPE-conditioned medium was
1.75 ng/ml under normal culture conditions (Fig. 2B). Under
hypoxic conditions, the VEGF concentration in the medium
increased to 2.8 ng/ml. If proteasome activity was inhibited,
levels of VEGF in the medium increased to 3.5 ng/ml
(Fig. 2B). Since both hypoxia and proteasome inhibition stabi-
lize HIF-1a in RPE cells and both enhance the expression and
secretion of VEGF, these data suggest that stabilization of
HIF-1a and enhanced expression of VEGF are functionally re-
lated. To further test this hypothesis, we assessed the effect of
HIF-1a levels on VEGF expression by overexpression of HIF-
1a in RPE. As compared to RPE transfected with empty
pcDNA3 vector, cells transfected with pcDNA3 vector encod-
ing HIF-1a expressed higher levels of VEGF (w2.5-fold)
(Fig. 2C). Because only w40% of the cells were transfectedunder these conditions, the effect of HIF-1a on VEGF expres-
sion was underestimated. Taken together, these data indicate
that accumulation of HIF-1a in RPE accounts, at least in
part, for the enhancement in expression and production of
VEGF upon proteasome inhibition. However, we cannot rule
out the possibility that enhanced expression and secretion of
VEGF upon proteasome inhibition is caused by other mecha-
nisms, in addition to accumulation of HIF-1a.
In addition to VEGF, other factors, such as Ang-1 and Ang-
2, also play roles in the formation and remodeling of new ves-
sels. As shown in Fig. 3, the expression of these angiogenic
factors also transiently increased following proteasome inhibi-
tion. Upon inhibition of the proteasome for 4 h, Ang-1 and
Ang-2 mRNA levels increased 2.5-fold and 6.8-fold, respec-
tively (Fig. 3B and C). Unlike the prolonged over-expression
of VEGF, the expression of Ang-1 and Ang-2 returned to basal
levels when the proteasome was inhibited for longer than 8 h
(Fig. 3B and C). It is known that expression of Ang-1 and
Ang-2 is under the control of the HIF system, therefore the
transient increase in expression of Ang-1 and Ang-2 by protea-
some inhibition is probably mediated via the stabilization of
HIF-1a in RPE cells. However, the down-regulation of these
genes upon prolonged inhibition of the proteasome suggests
that the expression of Ang-1 and Ang-2 may also be controlled
by other unidentified mechanisms.
3.3. Proteasome inhibition decreases
NF-kB activation in RPE cells
We next determined whether proteasome inhibition affects
NF-kB activation. As in many other types of cells, the activa-
tion of NF-kB in RPE is a transient event. Addition of fresh
medium to the cells is sufficient to trigger the activation ofTable 1
Primers for real-time RTePCR
Gene Forward primer Reverse primer Tm (
C) Size of product (bp)
VEGF 50-CAGAATCATCACGAAGTG 50-TCTGCATGGTGATGTTGGAC 60 216
Ang-1 50-GTCGGAGATGGCCCAGATAC 50-GCTTTCTGGTCTGCTCTGCAG 60 110
Ang-2 50-TTCCTCCTGCCAGAGATGGA 50-TGCACCGAGTCATCGTATTCG 61 103
MCP-1 50AGATCTCAGTGCAGAGGCTCG 50-CACAGATCTCCTTGGCCACAA 60 103
GAPDH 50-TCACCATCTTCCAGGAGCGA 50-CTTCTCCATGGTGGTGAAGAC 60 103
1478 A.F. Fernandes et al. / Experimental Eye Research 83 (2006) 1472e1481NF-kB. This activation is likely induced by growth factors and
cytokines in the medium. It is known that various cytokines
can activate this pathway. The physical stress associated
with medium change could be also a factor for NF-kB activa-
tion, since NF-kB is a known stress-responsive transcription
factor. The pilot experiments showed that activation of NF-
kB was detectable as early as 15 min upon stimulation and
reached peak levels by 30e60 min. Thereafter the signal de-
clined and was barely detectable by 4 h. Therefore, we chose
30 and 60 min time points to study the effect of proteasome
inhibition on NF-kB activation in these experiments. ARPE-
19 cells were cultured in the presence or absence of MG132
for 30 and 60 min, nuclear extracts were prepared and electro-
phoretic mobility shift assays were performed for NF-kB. As
shown in Fig. 4A, NF-kB activity in control cells increased
in a time-dependent manner, peaking at 1 h after changing
the medium. When proteasome activity was inhibited by
MG132, the levels of NF-kB in the nuclei were less than
50% of those found in control cells at each time point
(Fig. 4A, compare lanes 3 and 4 with lanes 1 and 2, respec-
tively). Upon stimulation with TNFa, a classic activator of
the NF-kB pathway, NF-kB DNA-binding activity increased
significantly (Fig. 4B, lanes 1 and 2). Treatment with protea-
some inhibitor substantially attenuated the TNFa-induced ac-
tivation of NF-kB (Fig. 4B, compare lanes 3 and 4 with lanes 1
and 2). The supershift assay demonstrated that the NF-kB dim-
mer in ARPE-19 cells was mainly the p65/p50 heterodimer
(Fig. 4C). These data indicate that NF-kB activity in the
RPE is also regulated by the UPP.
3.4. Inhibition of the UPP in RPE reduces the
expression of MCP-1
It is known that the expression of MCP-1 is under the con-
trol of NF-kB (Uetama et al., 2003). Given the role of the
UPP in regulating NF-kB activity, we assessed the effects
of proteasome inhibition on the expression of MCP-1.
ARPE-19 cells were cultured in the presence of MG132 for
4 or 8 h. MCP-1 mRNA levels were assessed by real-time
RTePCR analysis and protein levels were determined by
ELISA. As shown in Fig. 5A, levels of MCP-1 mRNA de-
creased significantly after proteasome inhibition for 4 h or
longer. Under normal conditions, levels of MCP-1 in the me-
dium increased in a time-dependent manner (Fig. 5B), indi-
cating that the RPE cells continuously secrete MCP-1. Upon
proteasome inhibition, the concentration of MCP-1 secreted
by RPE decreased 70e80% as compared to untreated controls
(Fig. 5B). To confirm that the decreased expression of MCP-1
upon inhibition of the proteasome is caused by inhibition of
NF-kB activation, we tested the effect of TNFa on expression
of MCP-1. As predicted, levels of MCP-1 increased dramati-
cally upon incubation of ARPE-19 with TNFa (Fig. 5C).
Even in the presence of TNFa, proteasome inhibition reduced
the production of MCP-1 (Fig. 5C). These data suggest that
the decreased MCP-1 production by ARPE-19 cells upon in-
hibition of the proteasome is related to down-regulation of
NF-kB activity.3.5. Proteasome inhibition in differentiated ARPE-19 is
associated with accumulation of HIF-1a, increased
production of VEGF and decreased production of MCP-1
It is known that ARPE-19 differentiates and acquires many
RPE-like properties with prolonged time in culture at conflu-
ence. To determine if the data obtained using undifferentiated
ARPE-19 cells pertains to differentiated RPE, ARPE-19 cells
were cultured at confluence for 3 weeks and then we assessed
the effects of proteasome inhibition on levels of HIF-1a,
production of VEGF and MCP-1. Fig. 6 shows that, as in undif-
ferentiated ARPE-19, proteasome inhibition also resulted in
accumulation of HIF-1a (Fig. 6A), increased production of
VEGF (Fig. 6B), and decreased production of MCP-1
(Fig. 6C). However, the responses to proteasome inhibition in
differentiated RPE were less dramatic than those found in un-
differentiated RPE. The attenuated responses of differentiated
RPE to proteasome inhibitors may partially be related to the de-
creased cell permeability of these inhibitors, since the RPE
were surrounded by large quantity of extracellular matrix under
confluent conditions.
4. Discussion
Pro-angiogenic factors produced by RPE, such as VEGF,
play a central role in CNV development (Campochiaro et al.,
1999; Witmer et al., 2003). Although oxidative stress appears
to play a role in triggering expression of these growth factors
(Beatty et al., 2000; Zhou et al., 2005), the molecular mecha-
nisms underlying this molecular change remain unknown.
Since the UPP is involved in regulating several signal transduc-
tion pathways and its activity can be compromised upon oxida-
tive stress, we hypothesize that oxidative damage to the UPP in
RPE is a potential factor for stress-induced expression of pro-
angiogenic factors. Our current study tested this hypothesis by
inhibiting the UPP in RPE and assessing its effects on signal
transduction and on the expression of VEGF, Ang-1 and
Ang-2. Consistent with our hypothesis, we found that inhibit-
ing proteasome activity stabilized HIF-1a (Figs. 1 and 6) and
diminished the activation of NF-kB (Fig. 4) in RPE. Conse-
quently, the expression and secretion of VEGF by RPE in-
creased at least 2-fold (Figs. 2 and 6). The expression of
Ang-1 and Ang-2 also transiently increased upon inhibition
of the proteasome (Fig. 3). We also found that the expression
and secretion of MCP-1 by RPE decreased (60e80%) when
the UPP function was impaired (Fig. 6).
It is well known that the HIF system is a key transcriptional
regulator of pro-angiogenic factors, such as VEGF (Pugh and
Ratcliffe, 2003) and that HIF-1a is a substrate for the UPP. In
other types of cells, the levels of HIF-1a are mainly regulated
by oxygen-dependent and UPP-mediated degradation (Salceda
and Caro, 1997; Semenza, 2003; Hagg and Wennstrom, 2005).
The current work demonstrates that HIF-1a in RPE is also reg-
ulated in an UPP-dependent manner. Consistent with this find-
ing, a recent study showed that hypoxia could markedly
increase the expression of HIF-1a in RPE cells (Wang et al.,
2005). These data suggest that if the UPP function is
1479A.F. Fernandes et al. / Experimental Eye Research 83 (2006) 1472e1481compromised, RPE cells behave as if they were under hypoxic
conditions, expressing and secreting high levels of pro-angio-
genic factors (Blaauwgeers et al., 1999; Mousa et al., 1999;
Schlingemann, 2004; Vinores et al., 2006).
Regulation of pro-angiogenic factors is controlled by vari-
ous transcription factors. The stabilization of HIF-1a is likely
one of the mechanisms of the increased VEGF expression
and secretion by RPE upon proteasome inhibition. However,
it is not clear how proteasome inhibition enhanced the expres-
sion of Ang-1 and Ang-2. Although expression of Ang-2 is up-
regulated under hypoxia conditions (Mandriota et al., 2000),
the molecular structure of hypoxia-responsive element has
not been identified in the promoter region of Ang-2. Ang-1
and Ang-2 are a pair of closely related pro-angiogenic factors
and they share a common receptor, Tie-2. Unlike VEGF, Ang-1
does not promote proliferation of endothelial cells, but it in-
hibits apoptosis of endothelial cells and promotes migration
of endothelial cells and the maturation of newly formed ves-
sels. Ang-2, by antagonizing the function of Ang-1, promotes
VEGF-induced endothelial proliferation and sprouting (Hangai
et al., 2001). Because Ang-1 and Ang-2 compete for the same
receptor (Tie-2), the net effect may be determined by the Ang-
1/Ang-2 ratio. Although both Ang-1 and Ang-2 were tran-
siently up-regulated upon proteasome inhibition, the extent of
the up-regulation is different. Whereas expression of Ang-1 in-
creased by 2.5-fold, expression of Ang-2 increased up-to 7-fold
upon proteasome inhibition, resulting in a dramatic decrease in
the Ang-1/Ang-2 ratio. The parallel regulation in the expres-
sion of Ang-1 and Ang-2 upon proteasome inhibition suggests
that the cells have a self-control mechanism that maintains the
ratios of Ang-1/Ang-2 in a certain range. Data from the present
study indicate that impairment of the UPP function in RPE
could trigger the expression and secretion of growth factors
that favor the proliferation and migration of endothelial cells
and the angiogenesis process.
A recent study showed that deficiency in MCP-1 or its cog-
nate receptor Ccr-2 causes AMD-like features in mice, includ-
ing accumulation of RPE-lipofuscin, drusen, atrophy and CNV
(Ambati et al., 2003b). Since MCP-1 expression is controlled
by NF-kB (Ueda et al., 1994; Barnes and Karin, 1997; Martin
et al., 1997; Marumo et al., 1999) and NF-kB activation is reg-
ulated by the UPP, we expected that inhibition of proteasome
would down-regulate MCP-1 expression. Consistent with our
prediction, we found that proteasome inhibition reduced NF-
kB activation as demonstrated by decreasing binding of NF-
kB to DNA (Fig. 4), and decreased MCP-1 secretion by
RPE (Fig. 5). Consistent with the role of NF-kB in regulating
MCP-1 expression, activation of NF-kB by TNFa increased
the expression of MCP-1 (Fig. 5C). This result is consistent
with a previous report that showed that MCP-1 gene expres-
sion was blocked by proteasome inhibitors in endothelial cells
(Parry et al., 1998).
Taken together, these data suggest that the UPP plays an
important role in regulating gene expression in RPE. It is plau-
sible that impairment of the UPP by oxidative stress or other
insults may trigger the development of CNVand other features
of AMD. However, further studies are needed to elucidate ifimpairment of the UPP in RPE is related to AMD in animals
or humans.
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